
Age-related macular degeneration (AMD) is a degenerative eye condition that affects approximately ¼ of the population. Particularly in the western world, it is the most frequent cause of blindness in humans. In most cases, the chronic progression of the retinal condition is not curable, as the window of opportunity in which any therapeutic action can be taken is very small. One potential new form of treatment is presented by stem-cell therapy. Fraunhofer researchers have now developed a new method for the production and clinical application of stem-cell-based retinal implants, which could contribute towards the successful treatment of AMD. Their approach thereby is to replace damaged tissue with stem-cell-based transplants.
more info